The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals
Wedi'i Gadw mewn:
Krause, D., et al., The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals. European Addiction Research, vol. 24, n. 5, 2018, p. 255-265.
Ref.
548004
Lleoliad:
SIIS R.1142
Palabras clave:
Drogodependencias, Tabaco, Ansiedad, Abstinencia, Opiáceos, Naltrexona, Efectos, Tratamiento médico, Evaluación, Resultados, Estudio comparativo
Drogodependencias, Tabaco, Ansiedad, Abstinencia, Opiáceos, Naltrexona, Efectos, Tratamiento médico, Evaluación, Resultados, Estudio comparativo
Eitemau Tebyg: The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals
- USE OF ACAMPROSATE AND OPIOID ANTAGONISTS IN THE TREATMENT OF ALCOHOL DEPENDENCE: A EUROPEAN PERSPECTIVE
- CLINICAL EXPERIENCE WITH ANTAGONIST-INDUCED OPIATE WITHDRAWAL UNDER ANAESTHESIA
- AN ACUTE DOSE OF NICOTINE ENHANCES CUE-INDUCED COCAINE CRAVING
- PUBLIC POLICY STATEMENT ON OPIOID ANTAGONIST AGENT DETOXIFICATION UNDER SEDATION OR ANESTHESIA (OADUSA)
- EXPERIMENTALLY-INDUCED SPONTANEOUS OPIATE WITHDRAWAL: RELATIONSHIP TO CIGARETTE CRAVING AND EXPIRED AIR CARBON MONOXIDE
- CLONIDINE AND OPIATE RECEPTOR ANTAGONISTS IN THE TREATMENT OF HEROIN ADDICTION